Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients

Published:2017 Issue:2 Volume:11 Page:214-220
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Liu Lei¹²,Guo Renbo¹³,Zhang Xiang¹⁴,Liang Yiran¹⁵,Kong Feng⁶,Wang Jue⁶,Xu Zhonghua¹⁴

Affiliation:

1. Institute of Basic Medical Science and Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University

2. Department of Urology, Weihai Municipal Hospital

3. Department of Urology, Shandong Cancer Hospital and Institute

4. Department of Urology, Qilu Hospital of Shandong University

5. Department of Breast Surgery, Qilu Hospital of Shandong University

6. Central Laboratory, The Second Hospital of Shandong University

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/11/2/11_2016.01228/_pdf

Reference29 articles.

1. 1. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009; 373:1119-1132.

2. 2. Li Y, Trojer P, Xu CF, Cheung P, Kuo A, Drury WJ, 3rd, Qiao Q, Neubert TA, Xu RM, Gozani O, Reinberg D. The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate. J Biol Chem. 2009; 284:34283-34295.

3. 3. Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: A metabolic disease. Nat Rev Urol. 2010; 7:277-285.

4. 4. Liao L, Testa JR, Yang H. The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer. Cancer Genet. 2015; 208:206-214.

5. 5. Dalgliesh GL, Furge K, Greenman C, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature. 2010; 463:360-363.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis;Pathology - Research and Practice;2024-02

2. Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis;Pathology - Research and Practice;2024-01

3. Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort;Nature Communications;2023-12-16

4. Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy;iMeta;2023-11

5. Loss of SETD2‐mediated downregulation of intracellular and exosomal miRNA‐10b determines MAPK pathway activation and multidrug resistance in renal cancer;Molecular Carcinogenesis;2023-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3